Synjardy 5/850 mg tablet, Reference

DRUG2 trials

Sponsors

ADIUM

Conditions

Bioequivalence Study in Healthy Subjects

Unknown Phase

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 500 mg Tablets Under Fed Conditions.

CompletedNCT07633054

ADIUMBioequivalence Study in Healthy Subjects

Start: 2025-09-10End: 2025-11-24Updated: 2026-06-10

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 5 mg / 850 mg Tablets Under Fed Conditions.

CompletedNCT07633015

ADIUMBioequivalence Study in Healthy Subjects

Start: 2025-02-17End: 2025-04-29Updated: 2026-06-10

Related Papers

Bioequivalence Evaluation of Immediate-Release Empagliflozin/Metformin Fixed-Dose Combination Tablets Under Fed Conditions in Healthy Mexican Subjects and Exploratory Analysis of Metformin Dose Proportionality

Pharmaceuticals2026-07-31